Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07742215 BCD-248 Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07742215 BCD-248 Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07742215 clinical trial report covering BCD-248, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07741331 KH-607 Depressive Disorder, Major Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07741331 KH-607 Depressive Disorder, Major Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07741331 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07742735 Apraglutide Short Bowel Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07742735 Apraglutide Short Bowel Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07742735 clinical trial report covering Apraglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07743463 ASC-30 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07743463 ASC-30 Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07743463 clinical trial report covering ASC-30, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07743450 ASC-30 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07743450 ASC-30 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07743450 clinical trial report covering ASC-30, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07741045 TJ-0113 Young onset Parkinson disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07741045 TJ-0113 Young onset Parkinson disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07741045 clinical trial report covering TJ-0113, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07741409 Povidone-Iodine Dental Caries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07741409 Povidone-Iodine Dental Caries Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07741409 clinical trial report covering Povidone-Iodine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07742644 MMR-varicella zoster virus vaccine(GlaxoSmithKline Plc) Rubella Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07742644 MMR-varicella zoster virus vaccine(GlaxoSmithKline Plc) Rubella Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07742644 clinical trial report covering MMR-varicella zoster virus vaccine(GlaxoSmithKline Plc), Phase 3, endpoints, sponsor, geography, readout timing
Read →
NCT07740720 Dostarlimab-gxly MSI-H/dMMR Rectal Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07740720 Dostarlimab-gxly MSI-H/dMMR Rectal Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07740720 clinical trial report covering Dostarlimab-gxly, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07745504 Cagrilintide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07745504 Cagrilintide Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07745504 clinical trial report covering Cagrilintide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07743606 Naproxen Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07743606 Naproxen Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07743606 clinical trial report covering Naproxen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07743983 BGM-0504 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07743983 BGM-0504 Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
5 August 2026
NCT07743983 clinical trial report covering BGM-0504, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →